Company Filing History:
Years Active: 1995
Title: David L Harper: Innovating Nucleic Acid Sequencing
Introduction
David L Harper is an accomplished inventor based in Rockland, ME, USA. With a strong background in research and development, he has made significant contributions to the field of nucleic acid sequencing. His innovative work has been recognized through the granting of a patent, showcasing his commitment to advancing scientific knowledge.
Latest Patents
David L Harper holds one patent titled "Agarose compositions for nucleic acid sequencing." This invention provides a unique nucleic acid sequencing gel that comprises 2 to 10% of a gelling polysaccharide, preferably agarose, along with a denaturing agent and a non-gelling additive, such as glycerol. The addition of electrophoretic buffers further enhances its utility. This composition excels in resolving nucleic acid fragments that have a minimum length of 50 bases and can differentiate fragments based on variations as small as one base. This innovation has the potential to significantly improve the accuracy and efficiency of nucleic acid sequencing techniques.
Career Highlights
David works at FMC Corporation, where he continues to push the boundaries of innovation. His dedication to scientific advancement has positioned him as a valued contributor in his field. At FMC Corporation, David collaborates with his colleagues to develop cutting-edge solutions that address complex challenges in the life sciences sector.
Collaborations
Throughout his career, David L Harper has collaborated with several notable professionals, including Jonathan H Morgan and Samuel Nochumson. These collaborations reflect a strong network of support and shared expertise, essential for advancing research and development within their respective fields.
Conclusion
David L Harper's contributions to the field of nucleic acid sequencing through his patented agarose compositions exemplify the spirit of innovation and dedication to scientific progress. His work at FMC Corporation and collaborative efforts with esteemed colleagues position him as a significant figure in the realm of biotechnology. As the field of nucleic acid research continues to evolve, David's contributions will undoubtedly play a crucial role in shaping its future.